Welcome to EpilepsyU.com a social network dedicated to the epilepsy community

Share This Post

Cannabis Derived Medicine / Childhood Epilepsy / Community / Education / Epilepsy / Media / Medicine / Neurology / News / Parents / Research / Seizures / Social Media / Technology / Treatment

Synthetic Cannabis Treatment Tested on Humans

Synthetic Cannabis Treatment Tested on Humans

mj-leafExperimental synthetic [Cannabis] therapy for epilepsy being tested on humans

Zynerba Pharmaceuticals Inc. said Tuesday it has started the company’s first human testing of one of its experimental synthetic cannabinoid treatments.


Zynerba CEO Armando Anido ZEF NIKOLLA

The Devon, Pa., specialty pharmaceutical company initiated a phase-I clinical trial of ZYN002, a transdermal gel under development as a potential therapy for epilepsy. About 2.2 million people in the United States and 3.1 million in Europe and Japan are afflicted with epilepsy, a neurological disease that results in a predisposition to seizures.

Cannabinoids are naturally occurring compounds found in the cannabis plants, more commonly known as marijuana. The compounds act on cannabinoid receptors in cells that repress the release of neurotransmitters — which tell the body’s organs what to do —in the brain.

Share This Post

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Lost Password